11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/14/2024
3:31 PM | Verona Pharma (Subject)
| Form SC 13G | |
11/14/2024
8:47 AM | Deep Track Capital, LP (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
11/13/2024
7:46 PM | Verona Pharma (Subject)
VIVO VENTURES VII, LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:57 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G/A | |
|
11/07/2024
5:56 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:57 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:40 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:41 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
7:47 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
5:06 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:13 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:14 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:17 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:55 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
6:54 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:45 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:46 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:22 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
8:51 PM | Growth Equity Opportunities Fund IV, LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13D/A | |
08/12/2024
3:20 PM | Hahn Mark W (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:20 PM | Verona Pharma (Subject)
ZACCARDELLI DAVID (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
6:11 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:12 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:13 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:44 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:51 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
8:28 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:29 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:30 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
8:43 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verona Pharma (Subject)
| Form SC 13G | |
06/27/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:53 AM | Verona Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
8:09 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:22 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad) Trump's back in the White House, but Wall Street is pissed.
Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. |
05/09/2024
6:18 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:21 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:15 PM | Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:16 PM | Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Ullman Anders (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:18 PM | Sinha Vikas (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024
7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024
6:45 PM | Gupta Rishi (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024
8:40 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
7:15 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
8:00 AM | Verona Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:08 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
5:09 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
5:05 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/02/2024
5:07 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:15 PM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
4:09 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
